Glaxo produced early profits figures on Tuesday, showing six month growth of 4.3 percent, in an effort to strengthen its hand in a hostile bid of 7.6 billion pounds Lrb 18 billion dollars Rrb for Wellcome.
Glaxo rises 4.3 PC at half time strengthens value of Wellcome bid.